Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | XBP1 | P17861 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 3/20 | 0.36 |
| ▸ | CES1 | P23141 | 3/20 | 0.36 |
| ▸ | DAO | P14920 | 1/20 | 0.36 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL965081 | 0.82 | ATM (0.40) | SRCATMMEN1KMT2ALMNA | |
| SCHEMBL25912437 | 0.80 | ATM (0.39) | SRCATMMEN1KMT2ALMNA | |
| SCHEMBL22155799 | 0.78 | EGFR (0.38) | SRCATMMEN1KMT2ALMNA | |
| SCHEMBL9501089 | 0.78 | ATM (0.38) | SRCATMMEN1KMT2ALMNA | |
| SCHEMBL22157975 | 0.78 | CES1 (0.43) | SRCATMMEN1KMT2ALMNA | |
| SCHEMBL9867851 | 0.78 | SRC (0.44) | SRCATMLMNAMAPTXBP1 | |
| SCHEMBL18545987 | 0.76 | HDAC1 (0.47) | MEN1KMT2ALMNAMAPTSMN1; SMN2 | |
| SCHEMBL4789184 | 0.76 | MAPT (0.48) | ATMMEN1KMT2ALMNAMAPT | |
| SCHEMBL12066324 | 0.75 | CES1 (0.41) | SRCATMMEN1KMT2ALMNA | |
| SCHEMBL6067661 | 0.75 | ATM (0.44) | SRCATMLMNAMAPTXBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114853804-B | Method for synthesizing high-regioselectivity alpha-alkenyl stannane by hydrogenating terminal alkyne stannum marshi | 浙江大学 | 2024-07-05 | — | — | CN | disclosed |
| CN-114853804-A | Method for synthesizing high-regioselectivity alpha-alkenyl stannane by hydrogenation of terminal alkyne martensitic tin | 浙江大学 | 2022-08-05 | — | — | CN | disclosed |
| US-10195831-B2 | Adhesive film and method of manufacturing the same and display device including the adhesive film | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-02-05 | — | — | US | disclosed |
| WO-2016029439-A1 | ORGANOSILICON MODIFIED PHOTOINITIATOR AND PHOTO-CURABLE ADHESIVE COMPOSITION THEREOF | HENKEL (CHINA) COMPANY LIMITED (CN) | 2016-03-03 | — | — | WO | disclosed |
| WO-2015030151-A1 | CURABLE COMPOSITION FOR PHOTOIMPRINT AND METHOD OF PRODUCING FILM, OPTICAL COMPONENT, CIRCUIT BOARD, OR ELECTRONIC COMPONENT USING THE COMPOSITION | CANON KABUSHIKI KAISHA (JP) | 2015-03-05 | — | — | WO | disclosed |
| US-20150010766-A1 | ADHESIVE FILM AND METHOD OF MANUFACTURING THE SAME AND DISPLAY DEVICE INCLUDING THE ADHESIVE FILM | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-01-08 | — | — | US | disclosed |
| US-20150010766-A1 | ADHESIVE FILM AND METHOD OF MANUFACTURING THE SAME AND DISPLAY DEVICE INCLUDING THE ADHESIVE FILM | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-01-08 | — | — | US | disclosed |
| WO-2014006141-A1 | RADIATION-CURABLE ACRYLATE-BASED INK-JET PRINTING INK | HAPA AG (CH) | 2014-01-09 | — | — | WO | disclosed |
| US-20100121048-A1 | Cyclic Amine Compound and Use Thereof for the Prophylaxis or Treatment of Hypertension | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-05-13 | — | — | US | disclosed |
| EP-0945420-B1 | Process for the preparation of bisphenols | MITSUI CHEMICALS INC (JP) | 2002-06-12 | — | — | EP | disclosed |
| US-6316677-B1 | REACTING PHENOLIC COMPOUND WITH DIALKYLBENZENE, BIS(HYDROXYALKYL)BENZENE, OR (HYDROXYALKYL)-ALKENYLBENZENE; NEUTRALIZATION USING ANION EXCHANGE RESIN; CONCENTRATION, ISOLATION | MITSUI CHEMICALS, INC. (JP) | 2001-11-13 | — | — | US | disclosed |
| EP-0945420-A1 | Process for the preparation of bisphenols | Mitsui Chemicals, Inc. (JP) | 1999-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100121048-A1 | Cyclic Amine Compound and Use Thereof for the Prophylaxis or Treatment of Hypertension | REN, AGTR1, AGTR2 | SRC 967/4885ATM 2412/4885MEN1 750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.